In the authors' words
“Even though ET led to significantly greater improvement in exercise capacity in postmenopausal women with AI treated breast cancer than exercise counseling only, it did not exert any measurable effects on endothelial dysfunction.”
What was measured
- Fitness Reported an improvement
About the study
- Type
- Randomised trial
- Who took part
- Postmenopausal, breast cancer survivors
- How many
- 32
- How long
- 26 weeks
- Exercise
- Aerobic plus resistance
- Cited
- 2 times, per Europe PMC
- PubMed ID
- 35585836
How to read this. Each line is one study, summarised in plain language from its PubMed abstract, with the authors' own sentence underneath on the study page. A count of studies is not a verdict: trials differ in size, length and quality, and a result in one group of women may not hold in another. Nothing here is medical advice.
Summaries are generated, then checked by machine against the abstract they came from; any summary that could not be matched word for word was left out. Our clinical lead is reviewing the summaries topic by topic, and this note will change when that is done. Corpus last refreshed 2026-11-03. Spotted a mistake? Tell us and we will fix the summary or remove the study.
Similar studies
- A meta-analysis of 129 trials in postmenopausal women found aerobic, resistance and combined training increased cardiorespiratory fitness and lower-body strength, while only resistance training increased upper-body strength.
- A review of 28 randomised trials in postmenopausal women aged 50 to 65 found walking combined with resistance training could preserve weight and bone density and increase muscle strength.
- A meta-analysis of 29 RCTs in 2071 women with breast cancer found combined aerobic and resistance training improved fitness, fatigue and quality of life, with smaller benefits in postmenopausal women.
- A meta-analysis of 23 trials in 1001 postmenopausal women found concurrent aerobic and resistance training modestly improved body composition and metabolic markers, with no significant change in inflammation markers.